Tag: services

162 million 5G subscriptions added during the first quarter of 2026, bringing the total to 3.1 billionThe number of commercial differentiated connectivity service offerings...

BENGALURU, India, June 16, 2026 /PRNewswire/ -- KBR (NYSE: KBR) launched its inaugural Innovation Studio, powered by Applied Computing, in Bengaluru, India, establishing a...

HONG KONG, June 16, 2026 /PRNewswire/ -- Tencent Cloud, the cloud business of global leading technology company Tencent, today announced a strategic partnership with...

Starting 16th June, L50s Pro Ultra and L50 Ultra CE will be available on Amazon India, Dreame Technology India website, Croma, and select retail...

HONG KONG, June 16, 2026 /PRNewswire/ -- XTransfer, the world's leading B2B cross-border trade payment platform, is proud to announce that it has been...

MUMBAI, India, June 16, 2026 /PRNewswire/ -- InCred Capital, the institutional, wealth and asset management arm of InCred Group, today announced the launch of...

AS LHV Group’s May financial results reflected positive performance, with the results of all subsidiaries in line with the financial plan. LHV Group earned a consolidated net profit of EUR 9.1 million in May, with return on equity attributable to shareholders of 14.1%. Among the subsidiaries, AS LHV Pank earned EUR 9.8 million, LHV Bank Ltd EUR 0.3 million, AS LHV Varahaldus EUR 0.2 million and AS LHV Kindlustus EUR 0.4 million in net profit.

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

New collaboration provides framework between the Japan government and ItalyTOKYO, June 15, 2026 /PRNewswire/ -- Rapidus Corporation today announced that it signed a Memorandum of...

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/SASKATOON, SK, June 15, 2026 /CNW/ - Wescan Goldfields Inc. (TSXV: WGF)...

MORGANTOWN, W.Va., June 15, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Haider Jaffrey, DDS is acknowledged as a Pinnacle Lifetime Member for his...

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.